Recital 34, Regulation (EU) 2025/99

In forcesince 21 Jan 2025

For the active substances Aureobasidium pullulans (strains DSM 14940 and DSM 14941), Bacillus amyloliquefaciens subsp. plantarum D747, benalaxyl-M, imazamox, Pseudomonas sp. strain DSMZ 13134, pyriofenone and pyroxsulam, as the risk assessment has not yet been finalised by the respective rapporteur Member States and in light of the remaining steps to be completed in each renewal procedure, the duration of the extension of the approval periods should be set at 29 months.